Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 282-500-0 | CAS number: 84238-45-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://chesar.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2018-06-27 to 2018-06-29
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- 2017-10-09
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: MatTek Corporation Protocol: EpiOcular™ Eye Irritation Test (OCL-200-EIT) for the prediction of acute ocular irritation of chemicals; for use with MatTek Corporation’s Reconstructed Human EpiOcular™ Model
- Version / remarks:
- 29-06-2015
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- signed 2018-04-26
Test material
- Reference substance name:
- Benzenesulfonic acid, 4-dodecyl-, cerium(4+) salt, basic
- EC Number:
- 282-500-0
- EC Name:
- Benzenesulfonic acid, 4-dodecyl-, cerium(4+) salt, basic
- Cas Number:
- 84238-45-9
- IUPAC Name:
- Benzenesulfonic acid, 4-dodecyl-, cerium(4+) salt, basic
- Test material form:
- solid: particulate/powder
- Details on test material:
- - State of aggregation: brown powder
Constituent 1
- Specific details on test material used for the study:
- STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature, in a sealed container
Test animals / tissue source
- Details on test animals or tissues and environmental conditions:
- JUSTIFICATION OF THE TEST METHODS AND CONSIDERATIONS REGARDING APPLICABILITY:
The EpiOcular™ Eye Irritation Test (EIT) was validated by the European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) and Cosmetics Europe from 2008 to 2013. From this validation study and its independent peer review it was concluded that the EpiOcular™ EIT is able to correctly identify chemicals (both substances and mixtures) not requiring classification and labelling for eye irritation or serious eye damage according to UN GHS (i.e. “No Category”), and the test method was recommended as scientifically valid for this purpose. Therefore, it can be used for regulatory purposes as an initial step in the bottom-up approach or as one of the last steps in a top-down approach to test eye irritation/corrosion potential. It is not intended to differentiate between UN GHS “Category 1” (serious eye damage) and UN GHS “Category 2” (eye irritation) which would require additional testing.
RhCE TISSUE CONSTRUCT USED: EpiOcular™ (Lot No.: 27051; source: MatTek (Bratislava, Slovakia))
The test was carried out with the EpiOcular™ reconstructed human cornea-line epithelium (RhCE) model. The model consists of normal, human-derived epidermal keratinocytes which have been cultured to form a stratified, highly differentiated squamous epithelium morphologically similar to that found in a human cornea. The EpiOcular™ RhCE tissue construct consists of at least 3 viable layers of cells and a non-keratinized surface, showing a cornea-like structure analogous to that found in vivo.
Please also refer to the field "Attached background material" below.
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): approx. 50 mg (83.3 mg/cm²) of the test item - Duration of treatment / exposure:
- 6 ± 0.25 hours
- Observation period (in vivo):
- not applicable
- Duration of post- treatment incubation (in vitro):
- 18 ± 0.25 hours
- Number of animals or in vitro replicates:
- Number of EpiOcular tissues:
Test item: duplicates
Negative control: duplicates
Positive control: duplicates - Details on study design:
- PRE-TEST FOR DIRECT MTT-REDUCERS AND COLOURING TEST CHEMICALS
TEST FOR MTT INTERFERENCE
To check the non-specific MTT-reducing capability of the test item 50 mg of the test item were mixed per 1 mL MTT medium and incubated for 3 hours in a humidified incubator at 37 ± 2 °C, 5.0% CO2 / 95% air. After incubation verification of the colour by the unaided eye.
TEST FOR COLOUR INTERFERENCE
To check the colouring potential of the test item 50 mg of the test item were mixed per 1 mL Aqua dest. and per 2 mL isopropanol each in a 6-well plate. The water solution was incubated for at least 1 hour in a humidified incubator at 37 ± 2 °C, 5.0% CO2 / 95% air. The isopropanol solution was shaken on a plate shaker for 2 to 3 hours. After the incubation period, 2 x 200 µL aliquots per test solution were transferred into a 96-well plate, using 200 µL Aqua dest. and isopropanol as respective blanks and OD was measured in a range of 570 ± 30 nm without reference wavelength in a plate spectrophotometer. Since one of the two ODnet was > 0.08, or if the intrinsic colour of the test item is blue, black or dark-purple, the test item was checked for its tissue-colouring potential. For quantitative correction of results, the colorant control test was performed using two additional living tissues treated with 50 mg of the test item (TVT). All steps were performed exactly as described below in "Details on the test procedure used", except for the MTT-staining of the test item treated with tissues, which was incubated in medium without MTT.
EXPERIMENT - DETAILS ON THE TEST PROCEDURE USED:
- upon receipt of the EpiOcular™, the tissues were equilibrated in the 24-well shipment plate to room temperature for about 15 minutes.
- then, the EpiOcular™ tissues were transferred into 6-well plates containing 1 mL pre-warmed assay medium per well and incubated for 1 hour in a humidified incubator at 37 ± 2 °C, 5.0% CO2 / 95% air.
- next, the inserts were transferred into new 6-well plates containing 1 mL fresh assay medium per well and pre-incubated in a humidified incubator at 37 ± 2 °C, 5.0% CO2 / 95% air for 23.5 hours.
- after the overnight incubation the tissues were pre-treated with 20 µL of DPBS-buffer and incubated for 30 ± 2 minutes in a humidified incubator at 37 ± 2 °C, 5.0% CO2 / 95% air.
- afterwards, the tissues were treated with each dose group in duplicate, starting with the negative and positive control follwoed by the test item.
- after dosing, the inserts were placed back into the culture medium and were incubated for 6 ± 0.25 h at 37 ± 2 °C, 5.0% CO2 / 95% air.
- at the end of the exposure period the test item and control substances were removed by extensively rinsing the tissue with DPBS.
- complete test material could not be washed off resulting in little remaining test material on the skin tissue surface. As this little residues were only at the edge of the tissues, the impact on the results are presumably negligible.
- after rinsing the inserts were transferred to and immersed in a prepared 12-well plate, containing fresh pre-warmed assay medium per well and incubated for 25 ± 2 minutes at room temperature.
- then, the inserts were removed from the assay medium, the medium was decanted off the tissue and the tissues were blotted.
- the inserts were transferred to a new 6-well plate containing pre-warmed assay medium and the tissues were incubated for 18 ± 0.25 hours at 37 ± 2°C, 5.0% CO2 / 95% air.
MTT ASSAY
- after the incubation period excess medium was removed and the inserts were transferred in a prepared 24-well plate containing 0.3 mL pre-warmed MTT medium and further incubated for 3 hours ± 15 minutes at 37 ± 2 °C, 5.0% CO2 / 95% air.
- following the MTT incubation period, the inserts were removed, the bottom of the inserts blotted and transferred into new 6-well plates, containing 2 mL of isopropanol to extract only the bottom of the tissues.
- extraction plates were sealed to inhibit isopropanol evaporation.
- extraction was carried out after storage overnight in the dark at 2 - 8 °C.
- at the end of the extraction period the tissues were not pierced to avoid contamination of the extract with remaining test item.
- inserts were discarded and the extracts were mixed three times using a pipette. If any visible cell/tissue fragments were in suspension, extracts were centrifuged to eliminate the fragments and avoid further possible interference with the absorbance readings.
- for each tissue 2 x 200 µL aliquots of the extract were transferred into a 96-well plate and optical density (OD) was measured at 570 nm using a filter band pass of maximum ± 30 nm in a plate spectrophotometer using isopropanol as a blank.
DATA ANALYSIS
- mean optical density (OD) of the two negative control tissues will be calculated after blank correction (corresponds to 100 % tissue viability).
- for each individual tissue treated with the test item or the positive control, the individual relative tissue viability is calculated according to the following formula: Relative viability (%) = [mean ODtest item/ positive control / ODmean of negative control] * 100
- for the test item and the positive control the mean relative viability ± relative standard deviation of the two individual tissues will be calculated and used for classification according to a prediction model.
PREDICTION MODEL:
- ocular irritation potential of the test item was predicted from the relative mean tissue viabilities obtained after treatment compared to the negative control tissues.
- if the mean percent tissue viability after exposure and post-exposure incubation is ≤ 60% tissue viability, no prediction can be made.
- if the mean percent tissue viability after exposure and post-exposure incubation is > 60%, the test chemical is identified as not requiring classification and labelling according to UN GHS (No Category).
TEST ACCEPTANCE CRITERIA:
The test meets acceptance criteria if:
- mean absolute OD570 nm of the negative control is > 0.8 and < 2.5
- mean relative tissue viability of the positive control is < 50%
- relative tissue viability difference of replicate tissues is < 20%.
- OD control values should not be below historically established boundaries/ positive and negative control mean values and acceptance ranges based on historical data.
Results and discussion
In vitro
Results
- Irritation parameter:
- other: % tissue viability (mean)
- Value:
- 1.3
- Vehicle controls validity:
- not examined
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- PRE-EXPERIMENT
TEST FOR MTT INTERFERENCE
The mixture did not turn blue/purple. So, the additional functional test with freeze-killed tissues and the quantitative corrections were not necessary.
TEST FOR COLOUR INTERFERENCE
The mixture of test item/Aqua dest. showed no colouring as compared to the solvent, but the mixture of test item/isopropanol showed colouring as compared to the solvent. Therefore, the absorption of the chemical in isopropanol was measured in the range of 570 ± 30 nm. The test item in isopropanol absorbed light in the relevant range:
ODnet(Aqua dest.) = meanODAqua dest. – mean ODBlank(Aqua dest.) = 0.0509 – 0.0429 = 0.008
ODnet(Isopropanol) = meanODIsopropanol – mean ODBlank(Isopropnaol) = 1.4277 – 0.4405 = 1.38365
As ODnet(Isopropanol) was >0.08, coloured tissue controls were performed for quantitative correction of results.
The non-specific colour of additional viable tissues (NSCliving) was calculated according to the following formula:
NSCliving [%] = [ODTVT/ODNC] * 100 = 0.2%
Difference of NSCliving of the two duplicate tissues must be < 20%, otherwise not accepted.
NSC1 [%] = [ODTVT1 / ODNC] * 100 = 0.2%
NSC2 [%] = [ODTVT2 / ODNC] * 100 = 0.2%
NSC1 – NSC2 = ± 0.0%
NSCliving was ≤ 60% (0.2%) relative to the negative control of living epidermis and could therefore be used for determination of the NSC-corrected mean relative tissue viability (NSCCV) according to the following formula:
NSCCV [%] = viabilityTM [%] – NSCliving [%] = 1.5% - 0.2% = 1.3%
EXPERIMENT
After treatment with the test item, the mean relative tissue viability compared to the relative mean tissue viability of the negative control was reduced to ≤ 60% (1.3%, NSCliving-corrected) after 6 hours treatment and 18 hours post-incubation. Since the mean percent tissue viability after exposure and post-exposure incubation is less than 60% tissue viability, no prediction of the ocular irritation potential of the test item can be made.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: mean absolute OD570 of the two negative control tissues was > 0.8 and < 2.5 (1.566)
- Acceptance criteria met for positive control: mean relative tissue viability (% negative control) of the positive control was < 50% (23.8%).
- The maximum inter-tissue difference of replicate tissues of all dose groups was < 20% (0.1 - 11.6%).
- The absorbance values were not below historically established boundaries.
Any other information on results incl. tables
Table 1: Result of the test item benzenesulfonic acid, 4-dodecyl-, cerium(4+) salt, basic
Name |
Negative Control |
Positive Control |
Test item |
||||
Tissue |
1 |
2 |
1 |
2 |
1 |
2 |
|
Absolute OD570values |
1.665 |
1.474 |
0.423 |
0.393 |
0.068 |
0.067 |
|
1.645 |
1.481 |
0.421 |
0.392 |
0.068 |
0.065 |
||
Mean Absolute OD570values |
1.566**** |
0.407 |
0.067 |
||||
OD570values |
1.620 |
1.429 |
0.378 |
0.348 |
0.023 |
0.022 |
|
1.600 |
1.437 |
0.377 |
0.347 |
0.023 |
0.021 |
||
Mean OD570of the duplicates |
1.610 |
1.433 |
0.377 |
0.347 |
0.023 |
0.021 |
|
Total Mean OD570of 2 Replicate Tissues (blank corrected) |
1.521* |
0.362 |
0.022 |
||||
SD of Mean OD570of the Replicates (Blank Corrected) |
0.125 |
0.021 |
0.001 |
||||
Relative tissue viability [%] |
105.8 |
94.2 |
24.8 |
22.8 |
1.5 |
1.4 |
|
Relative tissue viability difference [%]*** |
11.6 |
2.0 |
0.1 |
||||
Mean of relative tissue viability [%] |
100.0 |
23.8** |
1.5 |
||||
Mean Relative Tissue Viability [%] - |
- |
- |
1.3 |
* Corrected mean OD570of the negative control corresponds to 100% absolute tissue viability
** Mean relative tissue viability of the positive control is < 50%
*** Relative tissue viability difference of replicate tissues is < 20%
**** Mean absolute OD570of the negative control tissues is > 0.8 and < 2.5.
Table 2: Result of the NSCliving control
NSCliving |
TVT |
||
Tissue |
1 |
2 |
|
absolute OD570 -values |
0.048 |
0.048 |
|
0.048 |
0.048 |
||
absolute OD570 - |
0.003 |
0.003 |
|
0.003 |
0.003 |
||
mean OD570 |
0.003 |
0.003 |
|
total mean OD570 |
0.003 |
||
SD OD570 |
0.000 |
||
NSCliving[%] |
0.2 |
||
Relative Tissue Viability [%] |
- |
||
Mean Relative Tissue Viability [%] |
- |
||
SD Tissue Viability [%] |
- |
||
CV [% Viabilities] |
- |
Table 3: Historical data (from 2017 - 2018)
|
Mean Absolute OD570±30nmNC |
MeanAbsoluteOD570±30nmPC |
Mean Relative Viability [%] PC |
SD Viability [%] |
Mean |
1.686 |
0.423 |
23.4 |
6.0 |
SD |
0.269 |
0.205 |
12.4 |
5.7 |
Range of |
1.147 – 2.224 |
0.012 – 0.833 |
0.0 – 48.1 |
0.0 – 17.3 |
n |
25 |
25 |
25 |
114 |
LCL: Lower control limit (95%, mean – 2*SD)
UCL: Upper control limit (95%, mean + 2*SD)
n: number of control values
Applicant's summary and conclusion
- Interpretation of results:
- study cannot be used for classification
- Conclusions:
- According to the reconstructed human cornea-like epithelium (RhCE) test method, since the mean percent tissue viability after exposure and post-exposure incubation is less than 60% tissue viability (1.3 %, NSCliving-corrected), no prediction of the ocular irritation potential of the benzenesulfonic acid, 4-dodecyl-, cerium(4+) salt, basic can be made.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)